PHARMARON: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 17.16%
HK Disclosure
Yesterday
On September 11, 2026, JPMorgan Chase & Co. acquired 1.72 million shares of PHARMARON (03759) (H shares) by way of taking a security interest in shares. The transaction was conducted off-exchange for cash consideration at an average of HKD 27.4278 per share, involving approximately HKD 47.09 million. This was not a direct secondary-market dealing.
Prior to the acquisition, JPMorgan Chase & Co.'s long position in PHARMARON was 60.06 million shares, representing 16.68%; following the acquisition, the holding changed to 61.78 million shares, with the long position ratio rising to 17.16%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.